Literature DB >> 15923632

Mutation of SENP1/SuPr-2 reveals an essential role for desumoylation in mouse development.

Taihei Yamaguchi1, Prashant Sharma, Meropi Athanasiou, Amit Kumar, Satoru Yamada, Michael R Kuehn.   

Abstract

The covalent modification of proteins by the small ubiquitin-like protein SUMO has been implicated in the regulation of numerous biological processes, including nucleocytoplasmic transport, genomic stability, and gene transcription. Sumoylation occurs by a multienzyme process similar to ubiquitination and, in Saccharomyces cerevisiae, is reversed by desumoylating enzymes encoded by the Ulp1 and Smt4/Ulp2 genes. The physiological importance of desumoylation has been revealed by mutations in either gene, which lead to nonoverlapping defects in cell cycle transition and meiosis. Several mammalian Ulp homologues have been identified, but, to date, nothing is known of the phenotypic effects of their loss of function. Here, we describe a random retroviral insertional mutation of one homolog, mouse SENP1/SuPr-2. The mutation causes increased steady-state levels of the sumoylated forms of a number of proteins and results in placental abnormalities incompatible with embryonic development. Our findings provide the first insight into the critical importance of regulating sumoylation in mammals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923632      PMCID: PMC1140580          DOI: 10.1128/MCB.25.12.5171-5182.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  Modification with SUMO. A role in transcriptional regulation.

Authors:  Alexis Verger; José Perdomo; Merlin Crossley
Journal:  EMBO Rep       Date:  2003-02       Impact factor: 8.807

2.  SUMO-1 protease-1 regulates gene transcription through PML.

Authors:  Jennifer L Best; Soula Ganiatsas; Sadhana Agarwal; Austin Changou; Paolo Salomoni; Orian Shirihai; Pamela B Meluh; Pier Paolo Pandolfi; Leonard I Zon
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

3.  Ubiquitin branches out.

Authors:  Erica S Johnson
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

4.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.

Authors:  J M Desterro; M S Rodriguez; R T Hay
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

Review 5.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 6.  On the road to repair: PCNA encounters SUMO and ubiquitin modifications.

Authors:  Michael J Matunis
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

7.  A new protease required for cell-cycle progression in yeast.

Authors:  S J Li; M Hochstrasser
Journal:  Nature       Date:  1999-03-18       Impact factor: 49.962

8.  Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.

Authors:  Y H Kim; C Y Choi; Y Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

9.  The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugation system.

Authors:  Masahide Tojo; Kazuhito Matsuzaki; Takeshi Minami; Yoshiomi Honda; Hideyo Yasuda; Tsutomu Chiba; Hideyuki Saya; Yoshiaki Fujii-Kuriyama; Mitsuyoshi Nakao
Journal:  J Biol Chem       Date:  2002-09-26       Impact factor: 5.157

10.  The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization, and substrate specificity.

Authors:  Shyr-Jiann Li; Mark Hochstrasser
Journal:  J Cell Biol       Date:  2003-03-24       Impact factor: 10.539

View more
  50 in total

1.  N4BP1 is a newly identified nucleolar protein that undergoes SUMO-regulated polyubiquitylation and proteasomal turnover at promyelocytic leukemia nuclear bodies.

Authors:  Prashant Sharma; Rodolfo Murillas; Huafeng Zhang; Michael R Kuehn
Journal:  J Cell Sci       Date:  2010-03-16       Impact factor: 5.285

2.  SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation.

Authors:  Thang Van Nguyen; Pornpimon Angkasekwinai; Hong Dou; Feng-Ming Lin; Long-Sheng Lu; Jinke Cheng; Y Eugene Chin; Chen Dong; Edward T H Yeh
Journal:  Mol Cell       Date:  2012-01-27       Impact factor: 17.970

3.  The SUMO-specific protease SENP5 is required for cell division.

Authors:  Alessandra Di Bacco; Jian Ouyang; Hsiang-Ying Lee; Andre Catic; Hidde Ploegh; Grace Gill
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 4.  SUMOylation and De-SUMOylation: wrestling with life's processes.

Authors:  Edward T H Yeh
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 5.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

6.  Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.

Authors:  Christopher D Lima; David Reverter
Journal:  J Biol Chem       Date:  2008-09-16       Impact factor: 5.157

Review 7.  PIAS proteins: pleiotropic interactors associated with SUMO.

Authors:  Miia M Rytinki; Sanna Kaikkonen; Petri Pehkonen; Tiina Jääskeläinen; Jorma J Palvimo
Journal:  Cell Mol Life Sci       Date:  2009-06-13       Impact factor: 9.261

8.  SENP1-modulated sumoylation regulates retinoblastoma protein (RB) and Lamin A/C interaction and stabilization.

Authors:  P Sharma; M R Kuehn
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

Review 9.  Emerging roles of the SUMO pathway in development.

Authors:  Hilda Lomelí; Martha Vázquez
Journal:  Cell Mol Life Sci       Date:  2011-09-04       Impact factor: 9.261

10.  SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.

Authors:  Jinke Cheng; Xunlei Kang; Sui Zhang; Edward T H Yeh
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.